Heidi J.A. Wallweber

4.4k total citations · 1 hit paper
21 papers, 2.5k citations indexed

About

Heidi J.A. Wallweber is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Heidi J.A. Wallweber has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Heidi J.A. Wallweber's work include Synthesis and biological activity (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Mechanisms and Therapy (3 papers). Heidi J.A. Wallweber is often cited by papers focused on Synthesis and biological activity (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer Mechanisms and Therapy (3 papers). Heidi J.A. Wallweber collaborates with scholars based in United States, France and Russia. Heidi J.A. Wallweber's co-authors include Kurt Deshayes, Domagoj Vucic, Wayne J. Fairbrother, Eugene Varfolomeev, Kerry Zobel, Linda O. Elliott, Patrick J. Lupardus, John A. Flygare, Anna Fedorova and Vishva M. Dixit and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Heidi J.A. Wallweber

21 papers receiving 2.4k citations

Hit Papers

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κ... 2007 2026 2013 2019 2007 250 500 750 1000

Peers

Heidi J.A. Wallweber
Martin Hegen United States
Karen A. Cadwallader United Kingdom
Stacey J. Baker United States
Nupam P. Mahajan United States
Patricia G. McCaffrey United States
Jianping Yin United States
Sajjad A. Qureshi United States
Martin Hegen United States
Heidi J.A. Wallweber
Citations per year, relative to Heidi J.A. Wallweber Heidi J.A. Wallweber (= 1×) peers Martin Hegen

Countries citing papers authored by Heidi J.A. Wallweber

Since Specialization
Citations

This map shows the geographic impact of Heidi J.A. Wallweber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi J.A. Wallweber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi J.A. Wallweber more than expected).

Fields of papers citing papers by Heidi J.A. Wallweber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi J.A. Wallweber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi J.A. Wallweber. The network helps show where Heidi J.A. Wallweber may publish in the future.

Co-authorship network of co-authors of Heidi J.A. Wallweber

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi J.A. Wallweber. A scholar is included among the top collaborators of Heidi J.A. Wallweber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi J.A. Wallweber. Heidi J.A. Wallweber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrao, Ryan, Heidi J.A. Wallweber, & Patrick J. Lupardus. (2018). Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation. eLife. 7. 42 indexed citations
2.
Wang, Tzu-Ming, Brandon M. Brown, Lunbin Deng, et al.. (2017). A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain. Neuropharmacology. 121. 204–218. 32 indexed citations
3.
Wang, Xiaojing, Aleksandr Kolesnikov, Suzanne Tay, et al.. (2017). Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability. Journal of Medicinal Chemistry. 60(10). 4458–4473. 19 indexed citations
4.
Hackos, David H., Patrick J. Lupardus, Teddy Grand, et al.. (2016). Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Neuron. 89(5). 983–999. 139 indexed citations
5.
Ferrao, Ryan, Heidi J.A. Wallweber, Hoangdung Ho, et al.. (2016). The Structural Basis for Class II Cytokine Receptor Recognition by JAK1. Structure. 24(6). 897–905. 57 indexed citations
6.
Hu, Huiyong, Xiaojing Wang, Jae H. Chang, et al.. (2015). Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(22). 5258–5264. 19 indexed citations
7.
Wallweber, Heidi J.A., Christine Tam, Yvonne Franke, Melissa A. Starovasnik, & Patrick J. Lupardus. (2014). Structural basis of recognition of interferon-α receptor by tyrosine kinase 2. Nature Structural & Molecular Biology. 21(5). 443–448. 111 indexed citations
8.
Lupardus, Patrick J., Mark Ultsch, Heidi J.A. Wallweber, et al.. (2014). Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition. Proceedings of the National Academy of Sciences. 111(22). 8025–8030. 155 indexed citations
9.
Wang, Xiaojing, Steven Magnuson, Huiyong Hu, et al.. (2013). Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters. 23(11). 3149–3153. 55 indexed citations
10.
Bowman, Krista K., Jianwen A. Feng, Terry D. Crawford, et al.. (2012). The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site. Structure. 20(10). 1704–1714. 50 indexed citations
11.
Dueber, Erin C., Allyn J. Schoeffler, Andreas Lingel, et al.. (2011). Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination. Science. 334(6054). 376–380. 169 indexed citations
12.
Gordon, Nathaniel C., Samantha Lien, Jeremy Johnson, et al.. (2009). Multiple Novel Classes of APRIL-specific Receptor-blocking Peptides Isolated by Phage Display. Journal of Molecular Biology. 396(1). 166–177. 7 indexed citations
13.
Varfolomeev, Eugene, John W. Blankenship, Anna Fedorova, et al.. (2007). IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis. Cell. 131(4). 669–681. 1013 indexed citations breakdown →
14.
Lee, Chingwei V., S.G. Hymowitz, Heidi J.A. Wallweber, et al.. (2006). Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood. 108(9). 3103–3111. 48 indexed citations
15.
Zobel, Kerry, Lan Wang, Eugene Varfolomeev, et al.. (2006). Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs. ACS Chemical Biology. 1(8). 525–533. 148 indexed citations
16.
Zobel, Kerry, Lan Wang, Eugene Varfolomeev, et al.. (2006). Correction: Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs. ACS Chemical Biology. 1(9). 601–601. 3 indexed citations
17.
Patel, Darshana, Heidi J.A. Wallweber, Jianping Yin, et al.. (2004). Engineering an APRIL-specific B Cell Maturation Antigen. Journal of Biological Chemistry. 279(16). 16727–16735. 50 indexed citations
18.
Hymowitz, S.G., Darshana Patel, Heidi J.A. Wallweber, et al.. (2004). Structures of APRIL-Receptor Complexes. Journal of Biological Chemistry. 280(8). 7218–7227. 126 indexed citations
19.
Wallweber, Heidi J.A., Deanne M. Compaan, Melissa A. Starovasnik, & S.G. Hymowitz. (2004). The Crystal Structure of A Proliferation-inducing Ligand, APRIL. Journal of Molecular Biology. 343(2). 283–290. 49 indexed citations
20.
Hymowitz, S.G., Deanne M. Compaan, Minhong Yan, et al.. (2003). The Crystal Structures of EDA-A1 and EDA-A2. Structure. 11(12). 1513–1520. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026